CoA – Tecentriq | Atezolizumab | PD-L1 | B0006B01

150,00 

Certificate of Analysis (CoA) is an official document issued by the manufacturer of the medicinal product. It contains information on some critical quality characteristics of the medicine. CoA’s are available only for some medicines and limited batches. Customers can order the medicinal product CoA together with the aliquots of the same batch.

Additional information

Original Manufacturer

Roche Pharma AG

Batch Number

B0006B01

Original therapeutic expiry date [see Note 1]

03/2022